Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis
Digestive and Liver Disease · 2024
DOI: 10.1016/j.dld.2024.06.008 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Tom Konikoff und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Infliximab, Antibodies, Monoclonal, Humanized, Gastrointestinal Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Rabin Medical Center Innovation Lab, Rabin Medical Center, Petah Tikva, Israel.
- Faculty of Agriculture, Food and Environment, Hebrew University of Jerusalem, Rehovot, Israel.
- Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel; Division of Gastroenterology, Sheba Medical Center, Ramat Gan, Israel.
- Division of Gastroenterology, Rambam Healthcare campus, Haifa, Israel; Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
- Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Internal Medicine "D", Rabin Medical Center, Petah Tikva, Israel.
Zitieren
APA
Konikoff, T., Loebl, N., Yanai, H., Libchik, D., Kopylov, U., Albshesh, A., Weisshof, R., Ghersin, I., Bendersky, A. G., Avni-Biron, I., Snir, Y., Banai, H., Broytman, Y., Perl, L., Dotan, I., & Ollech, J. E. (2024). Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.06.008
Vancouver
Konikoff T, Loebl N, Yanai H, Libchik D, Kopylov U, Albshesh A, et al. Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2024.06.008
BibTeX
@article{Konikoff2024,
author = {Konikoff, Tom and Loebl, Nadav and Yanai, Henit and Libchik, Dror and Kopylov, Uri and Albshesh, Ahmad and Weisshof, Roni and Ghersin, Itai and Bendersky, Ahinoam Glusman and Avni-Biron, Irit and Snir, Yifat and Banai, Hagar and Broytman, Yelena and Perl, Leor and Dotan, Iris and Ollech, Jacob E},
title = {Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis},
journal = {Digestive and Liver Disease},
year = {2024},
doi = {10.1016/j.dld.2024.06.008}
}
EUVIMED